TY - JOUR
T1 - Correction to
T2 - Burdens of type 2 diabetes and cardiovascular disease attributable to sugar-sweetened beverages in 184 countries (Nature Medicine, (2025), 31, 2, (552-564), 10.1038/s41591-024-03345-4)
AU - Lara Castor, Laura
AU - O’Hearn, Meghan
AU - Zhang, Jianyi
AU - Barquera, Simon
AU - Zello, Gordon
AU - Ersino, Getahun
AU - Fisberg, Regina
AU - Skeaff, Sheila
AU - Jimenez, Elizabeth Yakes
AU - Freese, Riitta
AU - Jayawardena, Ranil
AU - Ochoa Avilés, Angélica María
AU - Ortiz Ulloa, Silvia Johana
AU - Hakeem, Rubina
AU - Mozaffarian, Dariush
AU - Trichopoulou, Antonia
N1 - Publisher Copyright:
© The Author(s) 2025.
PY - 2025/1/6
Y1 - 2025/1/6
N2 - In the version of the article initially published, in the eighth paragraph of the Discussion, the text “Among large nations, the largest increases in SSB-related T2D burdens were in Mexico, Thailand and the United Kingdom, and in CVD burdens, Colombia, Nigeria, Thailand and Russia. These changes align with rises in SSB consumption in these nations12. Similarly, declining SSB-related cardiometabolic burdens in Brazil, the United States and the United Kingdom (for CVD) are consistent with their decreasing SSB consumption from 1990 to 202012” was incorrect and has now been updated to “Among largely populated nations, the largest increases in SSB-related T2D incidence was in Colombia, USA and Argentina; and in CVD incidence, Nigeria, Russia, Colombia and Thailand. These changes generally align with rises in SSB consumption in these nations, except in the US where slight declines in SSB consumption were offset by increased burdens of diabetes 12. Similarly, declining SSB-related cardiometabolic burdens in Turkey, Brazil, and the United States and the United Kingdom for CVD are consistent with their decreasing SSB consumption from 1990 to 202012.” Additionally, Supplementary Data 1 and 2 have been updated to remove decimals in values greater than 100
AB - In the version of the article initially published, in the eighth paragraph of the Discussion, the text “Among large nations, the largest increases in SSB-related T2D burdens were in Mexico, Thailand and the United Kingdom, and in CVD burdens, Colombia, Nigeria, Thailand and Russia. These changes align with rises in SSB consumption in these nations12. Similarly, declining SSB-related cardiometabolic burdens in Brazil, the United States and the United Kingdom (for CVD) are consistent with their decreasing SSB consumption from 1990 to 202012” was incorrect and has now been updated to “Among largely populated nations, the largest increases in SSB-related T2D incidence was in Colombia, USA and Argentina; and in CVD incidence, Nigeria, Russia, Colombia and Thailand. These changes generally align with rises in SSB consumption in these nations, except in the US where slight declines in SSB consumption were offset by increased burdens of diabetes 12. Similarly, declining SSB-related cardiometabolic burdens in Turkey, Brazil, and the United States and the United Kingdom for CVD are consistent with their decreasing SSB consumption from 1990 to 202012.” Additionally, Supplementary Data 1 and 2 have been updated to remove decimals in values greater than 100
KW - Erratum
KW - Drug therapy
KW - Controlled study
UR - https://www.scopus.com/pages/publications/85217561850
UR - https://pubmed.ncbi.nlm.nih.gov/39762424
UR - https://www.nature.com/articles/s41591-025-03524-x
U2 - 10.1038/s41591-025-03524-x
DO - 10.1038/s41591-025-03524-x
M3 - Comentario/Debate
C2 - 39870818
AN - SCOPUS:85217561850
SN - 1078-8956
VL - 31
SP - 1
EP - 29
JO - Nature Medicine
JF - Nature Medicine
IS - 2
ER -